Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Benzgalantamine by AlphaCognition for Alzheimer's Disease: Likelihood of Approval
Benzgalantamine is under clinical development by AlphaCognition and currently in Pre-Registration for Alzheimer's Disease. According to GlobalData, Pre-Registration drugs for...